ir.refire-online.com
home ~ REFIRE online ~ Real Estate Intelligence Report - Europe
Declaration of PropertyCollection: create() should be compatible with ItemCollection: create() in /home/www refire/www.production/contenido/classes/class.properties.php. Declaration of PropertyItem: setField() should be compatible with Item: setField($field, $value, $safe = true) in /home/www refire/www.production/contenido/classes/class.properties.php. Declaration of DBFSCollection: create() should be compatible with ItemCollection: create() in /home/www refire/www.production/contenido/classes/class...
ir.regenxbio.com
Investor Overview - Investors - REGENXBIO
160; 0.20. Data as of 01/12/17 4:00 pm ET. Data provided by Nasdaq. Minimum 15 minutes delayed. REGENXBIO Provides Year-End 2016 Corporate Update. REGENXBIO and Voyager Therapeutics Announce Exercise of Options for Rights to NAV Vectors. ROCKVILLE, Md. and CAMBRIDGE, Mass., Nov. 29, 2016 (GLOBE NEWSWIRE) - REGENXBIO Inc. (Nasdaq:RGNX), a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy based ...On track to d...
ir.regions.com
Regions Financial Corporation - Investor Relations
Spectrum Card - Employee. Spectrum Card - Employer. 4:02 PM ET, 03/29/18. Regions is scheduled to release 1Q18 results on Friday April 20, 2018. Live teleconference and webcast beginning at 11am EST. Rarr; Learn More. Listen to the replay and read the transcript of Regions Executives present at the 2018 Credit Suisse Financial Services Conference. Rarr; Learn More. Website Terms of Use.
ir.regulusrx.com
Regulus Therapeutics Inc. - Investor Relations
Skip to primary content. Skip to secondary content. Road to the Clinic. Biology & Pharmacology. 4:00 PM ET on Aug 17, 2015. Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting. RNA therapeutics pipeline entering clinical development, an emerging. RNA biomarkers platform to support its therapeutic programs, and a rich intellectual property estate to retain its leadership in the. RNA field have enabled the formation ...
ir.rehabcare.com
Rehabcare : Overview
Founded in 1982, RehabCare is a leading provider of services across the post-acute continuum of care, operating programs and hospitals nationwide. RehabCare is a publicly traded company, listed on the NYSE under the symbol RHB, and is included in the Russell 2000 and Standard and Poor’s Small Cap 600 Indices. Could not find file ' aws.nasdaqomx.com irweb content3 IRXMLDATA 68 68419 Quotes.xml'. RehabCare Reports First Quarter 2011 Results. RehabCare To Announce First Quarter 2011 Results. Replication or ...
ir.relmada.com
Investor Relations :: Relmada Therapeutics, Inc. (RLMDD)
REL-1017 (dextromethadone, d-Methadone). Cash position on March 31, 2015. Headcount as of December 31, 2014. Common stock outstanding at May 15, 2015. Aug 17, 2015. Relmada Therapeutics Receives Health Canada Clearance to Commence Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist. Sign Up for E-Mail Alerts. Be the first to receive breaking news. Mar 31, 2015. Officers & Directors. Slide" data-cycle-swipe="true" data-cycle-timeout= 0. Douglas J. Beck. Michael D. Becker. Dr Mangano has ...
ir.remarkmedia.com
Company Information | Remark Holdings
Skip to main navigation. Investor Relations - Horizontal. Remark Holdings (NASDAQ: MARK. Mar 29, 2018. Remark Holdings Reports Fourth Quarter and Full Year 2017 Results. Mar 23, 2018. Remark Holdings Moves Up Fourth Quarter and Full Year 2017 Earnings Call to Thursday, March 29, 2018 at 8:30 am ET. Mar 16, 2018. Remark Holdings Sets Fourth Quarter and Full Year 2017 Earnings Call for Thursday, March 29, 2018 at 4:30 pm ET. Mar 09, 2018. Mar 05, 2018. Feb 12, 2018. View all press releases.
ir.remyinc.com
Remy - Investors Overview
Stock Quote and Chart. 160; 0.11. Data as of 08/17/15 4:00 pm ET. Minimum 20 minute delay. August 13, 2015. Remy Announces Early Termination Of Hart-Scott-Rodino Waiting Period For Pending Acquisition Of Remy By BorgWarner. August 03, 2015. Remy International, Inc. Announces Second Quarter 2015 Results. July 30, 2015. Remy International, Inc. Announces Declaration of Dividend on Common Stock; Cancels 2nd Quarter Earnings Conference Call. There are currently no events scheduled.
ir.renesola.com
Renesola - Investors - Investor Home
Stock Quote and Chart. Founded in 2005, and listed on the New York Stock Exchange in 2008, ReneSola (NYSE:SOL) is an international leading brand and technology provider of green energy products. Leveraging its global presence, expansive OEM and sales network, Renesola is well positioned to provide its highest quality green energy products and on-time services for EPC, installers, and green energy projects around the world. For more information, please visit www.renesola.com. Tel: 86-21-62809180 ext 105.
ir.rennovahealth.com
Investor Relations :: Rennova Health, Inc. (RNVA)
Rennova Health Provides Outlook for 2017. January 5, 2017. Rennova Health Provides Outlook for 2017. Jan 5, 2017. Ended Sep 30, 2016. Sign Up for Email Alerts. Be the first to receive breaking news. Jersey City, NJ 07310. 10320 N 56th Street. Tampa, FL 33617.
ir.renren-inc.com
Renren - INVESTOR RELATIONS - Overview
Started from university campuses in 2005, we now possess a nation-wide penetration with users across all demographics, particularly college students and young white-collar professionals. Our social networking platform serves as the foundation of our business and we aim to build a mobile-centric eco-system that embodies our user needs. As a leader in mobile social networking, we are dedicated in continuing to transform ourselves into a full-fledged mobile technology Company. 160; 0.02. This calendar conta...